Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
The Oncology Institute, Inc. (TOI) had Income from Continuous Operations of $-17.01M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$119.80M |
|
$-17.01M |
|
$102.30M |
|
$17.50M |
|
$131.01M |
|
$-11.21M |
|
$-5.93M |
|
$-17.14M |
|
$-17.14M |
|
$-17.01M |
|
|
Income from Continuous Operations |
$-17.01M |
$-17.01M |
|
$-17.01M |
|
$-11.21M |
|
$-8.28M |
|
93.20M |
|
93.20M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$104.79M |
|
$10.85M |
|
$55.01M |
|
$159.80M |
|
$64.78M |
|
$75.02M |
|
$104.00M |
|
$168.78M |
|
$-8.98M |
|
$-28.66M |
|
$-8.98M |
|
93.28M |
|
| Cash Flow Statement Financials | |
$-15.19M |
|
$-1.41M |
|
$-2.78M |
|
$49.67M |
|
$30.29M |
|
$-19.38M |
|
$2.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.62 |
|
-- |
|
-- |
|
1.14 |
|
-8.35 |
|
14.61% |
|
-9.36% |
|
-9.36% |
|
-- |
|
-14.31% |
|
-14.20% |
|
$-16.73M |
|
-- |
|
-- |
|
-- |
|
0.75 |
|
6.48 |
|
2.14 |
|
42.02 |
|
189.30% |
|
59.34% |
|
-10.64% |
|
-25.76% |
|
$-0.10 |
|
$-0.18 |
|
$-0.16 |
|